Advagene Biopharma Co., Ltd. (6709.TWO) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
About Advagene Biopharma Co., Ltd.
—
Advagene Biopharma Co., Ltd. is led by CEO Yu-Shen Hsu, employs 16 people, headquartered in Taipei, TW, publicly traded since 2018.
Advagene Biopharma Co., Ltd. (6709.TWO) stock trades at $24.00 with a market capitalization of $1.66B. The stock is valued at a negative price-to-earnings (P/E) ratio of -15.86, reflecting a net loss over the last twelve months, price-to-book of 3.99. Over the past 52 weeks the stock has ranged between $22.50 and $36.20, and currently trades 33.7% below its 52-week high.
On profitability, Advagene Biopharma Co., Ltd. generates a return on equity (ROE) of -33.48% (negative, reflecting a net loss).
Official website: www.advagene.com.tw
Advagene Biopharma Co., Ltd. (6709.TWO) — frequently asked questions
What is Advagene Biopharma Co., Ltd. (6709.TWO) stock price today?
Advagene Biopharma Co., Ltd. (6709.TWO) is currently trading at $24.00, down 4% today.
What is 6709.TWO P/E ratio?
Advagene Biopharma Co., Ltd.'s P/E ratio is -15.86. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 6709.TWO return on equity (ROE)?
Advagene Biopharma Co., Ltd.'s return on equity (ROE) is -33.48%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Advagene Biopharma Co., Ltd.'s market cap?
Advagene Biopharma Co., Ltd. has a market capitalization of $1.66B.
Does 6709.TWO pay a dividend?
Advagene Biopharma Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 6709.TWO carry?
Advagene Biopharma Co., Ltd. has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 6709.TWO's profit margin?
Advagene Biopharma Co., Ltd. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is 6709.TWO in?
Advagene Biopharma Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 6709.TWO listed on?
Advagene Biopharma Co., Ltd. trades on TWO under the ticker 6709.TWO.
What is 6709.TWO's 52-week range?
Over the last year Advagene Biopharma Co., Ltd. has traded between $22.50 and $36.20.
Related — Stocks
Popular Stocks
Screens 6709.TWO currently matches
On the figures above, Advagene Biopharma Co., Ltd. passes the filters for 8 of our ready-made screens, among them Low Debt Stocks, Small Cap Stocks, Debt Free Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.